| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $1.03 | 7,452 | 7,676 | 256,535 | Apr 05, 2023, 04:27 PM | |
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Mar 21, 2023 | Sale | $3.77 | 63,616 | 239,870 | 43,750 | Mar 23, 2023, 07:31 PM | |
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Mar 22, 2023 | Option Exercise | $1.03 | 65,698 | 67,669 | 109,448 | Mar 23, 2023, 07:31 PM | |
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Mar 22, 2023 | Sale | $3.72 | 65,698 | 244,640 | 43,750 | Mar 23, 2023, 07:31 PM | |
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Mar 23, 2023 | Option Exercise | $1.03 | 220,930 | 227,558 | 264,680 | Mar 23, 2023, 07:31 PM | |
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Mar 23, 2023 | Sale | $3.55 | 15,597 | 55,369 | 249,083 | Mar 23, 2023, 07:31 PM | |
| IPSC | Century Therapeutics, Inc. | Borges Luis | Chief Scientific Officer | Mar 21, 2023 | Option Exercise | $1.03 | 63,616 | 65,524 | 107,366 | Mar 23, 2023, 07:31 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Borges Luis | SVP, Research | Mar 01, 2017 | Option Exercise | $44.77 | 18,084 | 809,621 | 64,888 | Mar 03, 2017, 01:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Borges Luis | SVP, Research | Jan 03, 2017 | Option Exercise | $48.60 | 1,306 | 63,472 | 70,316 | Jan 05, 2017, 02:20 PM |
Menu